AltStreet
SEC filing record
Primary Source · SEC.gov

OurCrowd (Investment in Surgical Theater - II) L.P.

Single-Deal SPV2015 vintage506(b), 3(c)(1)

Raised

$89K

Investors

48

Min Invest

$10,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

Claim freeVerify, $480/yr

AltStreet Analysis

·

Generated from EDGAR primary sources

OurCrowd (Investment in Surgical Theater - II) L.P. is a single-deal special purpose vehicle formed to channel investor capital into Surgical Theater, filed by OurCrowd principals including Jonathan Medved and Steven Blumgart. The Form D reports $89K raised from 48 investors under a dual 506(b)/3(c)(1) exemption, with a stated $10K minimum investment, though the filing does not identify OurCrowd as a matched parent platform in this database.

This is a small, offshore-domiciled (BVI) single-company SPV typical of syndicate-style venture investing, where capital from many small check investors is pooled to fund one portfolio company. The combined 506(b)/3(c)(1) exemption and $10K minimum are consistent with retail-accessible VC syndicate structures rather than traditional institutional private funds, which typically carry $25K+ minimums and larger aggregate raises.

Data Flags

Total Amount Sold / Total InvestorsAverage investment of roughly $1,854 ($89K / 48 investors) falls well below the stated $10K minimum investment, suggesting either a data inconsistency on the filing or that reported totals reflect a partial/initial close rather than final commitments.
First Sale DateFirst sale date is not disclosed even though the filing reports completed sales ($89K from 48 investors), making it unclear when the offering period began.
State of IncorporationEntity is domiciled in the British Virgin Islands, an offshore jurisdiction, while soliciting and filing with the SEC — a cross-border fund structure common to OurCrowd-style syndicate SPVs.
ExemptionFiling claims both Rule 506(b) and Section 3(c)(1) exemptions simultaneously, a dual-exemption pattern typical of pooled syndicate vehicles rather than a single standard exemption.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001600464
Entity NameOurCrowd (Investment in Surgical Theater - II) L.P.
ExemptionRule 506(b), Section 3(c), Section 3(c)(1)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners.
Entity TypeLimited Partnership
Jurisdiction of OrganizationVirgin Islands, British
Year Organized2013
Issuer Address28 Derech Hebron, Jerusalem, L3 9108001
Phone972-2-636-9300
Industry / Fund TypePooled Investment Fund · Venture Capital Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer)
Securities TypeEquity, Pooled Investment Fund
First Sale Date—
Filing DateDecember 8, 2015
Accession Number0001465818-15-000048
Total Offering Amount$175,460
Total Amount Sold$88,600
Amount Remaining$86,860
Total Investors48
Non-Accredited InvestorsNone
Minimum Investment$10,000
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeNot Applicable
State (Issuer Address)L3
Amendment Count2 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

DDecember 8, 2015DMarch 10, 2014

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Item 3 changed on the Form D filed 2015-12-08: 1 related person added and 1 removed against the filing of 2014-03-10; 4 now listed. The names are in the Terminal feed.

Jonathan Medved

Executive Officer, Director · Jerusalem, L3

Steven Blumgart

Executive Officer, Director · Jerusalem, L3

Jay Kalish

Executive Officer · Jerusalem, L3

Robert Citron

Executive Officer · Jerusalem, L3

Questions About OurCrowd (Investment in Surgical Theater - II) L.P.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is OurCrowd (Investment in Surgical Theater - II) L.P.?

OurCrowd (Investment in Surgical Theater - II) L.P. is a Virgin Islands, British limited partnership organized in 2013 that filed a Form D with the SEC on December 8, 2015 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of equity and pooled investment fund interests.

Is OurCrowd (Investment in Surgical Theater - II) L.P. legit?

AltStreet does not rate legitimacy; it reports the public record. OurCrowd (Investment in Surgical Theater - II) L.P. filed a Form D with the SEC on December 8, 2015 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $88,600 sold to 48 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is OurCrowd (Investment in Surgical Theater - II) L.P. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that OurCrowd (Investment in Surgical Theater - II) L.P. claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has OurCrowd (Investment in Surgical Theater - II) L.P. raised?

OurCrowd (Investment in Surgical Theater - II) L.P. reported $88,600 sold from 48 investors of a $175,460 total offering as of the Form D filed December 8, 2015.

Who can invest in OurCrowd (Investment in Surgical Theater - II) L.P.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000.

What is the minimum investment in OurCrowd (Investment in Surgical Theater - II) L.P.?

The Form D lists $10,000 as the minimum investment accepted from any outside investor as of December 8, 2015. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling OurCrowd (Investment in Surgical Theater - II) L.P. and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind OurCrowd (Investment in Surgical Theater - II) L.P.?

The Form D lists 4 related persons: Jonathan Medved, executive officer, director (Mr. Medved is Managing Partner of the General Partner, OurCrowd International General Partner, LP); Steven Blumgart, executive officer, director (Mr. Blumgart is Managing Partner of the General Partner); Jay Kalish, executive officer (Mr. Kalish is Partner and General Counsel of the General Partner); Robert Citron, executive officer (Mr. Citron is CFO of the General Partner). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is OurCrowd (Investment in Surgical Theater - II) L.P. located?

The issuer's address on its SEC filings is 28 Derech Hebron, Jerusalem, L3 9108001. Its phone number of record is 972-2-636-9300. It is organized under the laws of Virgin Islands, British.

How long is the OurCrowd (Investment in Surgical Theater - II) L.P. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

How large is OurCrowd (Investment in Surgical Theater - II) L.P.?

The Form D reports a revenue range of Not Applicable.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Claim this profile, freeVerify this entity, $480/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.